Many clinical trials aren’t able to even move past the recruitment and enrollment stage. According to Deloitte, a “study on ...

NetraMark Holdings Inc. (the "Company" or "NetraMark") (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) a premier artificial intelligence (AI) company that is transforming clinical trials with AI powered ...

Generative artificial intelligence (generative AI or gen AI) in healthcare, has been in the spotlight for the last few years ...

The AI in Life Science Market is anticipated to experience a remarkable compound annual growth rate (CAGR) of around 25% in ...

Modern medicine is a marvel, with previously unimaginable cures and treatments now widely available. Think of advanced ...

Beyond Supply Chain: AI-Powered Innovations for Trial Optimization Alongside Clinical Supply Chain On Demand, Good AI and Intrinseque Health are introducing AI-powered solutions for protocol ...

QuantHealth, an AI-powered drug development platform trusted by the largest pharmaceutical companies, today announced registration has opened for its annual AI in Clinical Development Summit, which ...

AI promises to accelerate clinical trials, optimize supply chains and ... already demonstrating the power of AI-driven supply chain optimization, achieving significant cost savings and efficiency ...

Pruna AI, a European startup that has been working on compression algorithms for AI models, is making its optimization ...

RNA cancer vaccines are at the forefront of next-generation cancer immunotherapy, showcasing significant potential.

This collaboration with Intrinseque Health allows us to introduce AI-driven logistics automation and real-time supply optimization, making clinical trial execution more predictable and cost ...